Moderna partners with OpenAI to accelerate the development of life-saving treatments
Moderna deployed ChatGPT Enterprise to thousands of employees, seeing remarkable adoption across the company. They’ve created hundreds of custom versions of ChatGPT, including a pilot Dose ID GPT that uses the advanced data analysis feature to further evaluate and verify the optimal vaccine dose selected by the clinical study team. Learn more about Moderna’s work…
You must be logged in to post a comment.